Neurimmune Holding Investor
Neurimmune develops innovative immunotherapeutics for human diseases.
Technology:
Gene Therapy
Industry:
Biotechnology
Headquarters:
Schlieren, Zurich, Switzerland
Founded Date:
2006
Employees Number:
1-10
Funding Status:
Active
Estimated Revenue:
$1M to $10M
Register and Claim Ownership